Immune defense against pneumonic plague

Immunological Reviews

Volumn 225, Issue 1, 2008, Pages 256-271

  Smiley, Stephen T ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

Antibodies; Cellular immunity; Humoral immunity; Macrophages; Neutrophils; Phagocytes; Vaccine; Yersinia pestis

Indexed keywords

BACTERIAL PROTEIN; CELL ANTIGEN; CYTOKINE; GAMMA INTERFERON RECEPTOR; INACTIVATED VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIVE VACCINE; OPSONIN; PROTEIN F1; PROTEIN LCRV; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

BACTERIAL STRAIN; BIOLOGICAL WARFARE; CELL GROWTH; CELLULAR IMMUNITY; CHEMOTAXIS; GENE LOCUS; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PLAGUE; PNEUMONIA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; YERSINIA PESTIS; YERSINIOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; NEUTROPHILS; PLAGUE; PLAGUE VACCINE; VACCINES, SUBUNIT; YERSINIA PESTIS;

EID: 52049114659     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00674.x     Document Type: Review

References (168)

1. Pollitzer R. Plague. World Health Organization, Geneva, Switzerland, 1954.
2. Butler T. Plague and Other Yersinia Infections. New York : Plenum Press, 1983.
3. Perry RD, Fetherston JD. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997 10 : 35 66.
4. Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E. Plague Manual: Epidemiology, Distribution, Surveillance and Control WHO/CDS/CSR/EDC/99.2. World Health Organization, Geneva, Switzerland, 1999.
5. Brubaker RR. Yersinia pestis and bubonic plague. In : Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandte E, eds. The Prokaryotes, an Evolving Electronic Resource for the Microbiological Community. New York : Springer-Verlag, 2000.
6. Prentice MB, Rahalison L. Plague. Lancet 2007 369 : 1196 1207.
7. Ratsitorahina M, Chanteau S, Rahalison L, Ratsifasoamanana L, Boisier P. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 2000 355 : 111 113.
8. Plague, democratic republic of the Congo. Wkly Epidemiol Rec. World Health Organization, Geneva, Switzerland, 2005 80 : 65.
9. Guiyoule A, Rasoamanana B, Buchrieser C, Michel P, Chanteau S, Carniel E. Recent emergence of new variants of Yersinia pestis in Madagascar. J Clin Microbiol 1997 35 : 2826 2833.
10. Radnedge L, Agron PG, Worsham PL, Andersen GL. Genome plasticity in Yersinia pestis. Microbiology 2002 148 : 1687 1698.
11. Galimand M, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 1997 337 : 677 680.
12. Guiyoule A, et al. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg Infect Dis 2001 7 : 43 48.
13. Hinnebusch BJ, Rosso ML, Schwan TG, Carniel E. High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut. Mol Microbiol 2002 46 : 349 354.
14. Welch TJ, et al. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS ONE 2007 2 : e309.
15. Alibek K. Biohazard. New York : Random House, Inc, 1999.
16. Dennis DT. Plague as a biological weapon. In : Fong IW, Alibek K, eds. Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century. New York : Springer Science, 2005 : 37 64.
17. Zilinskas RA. The anti-plague system and the Soviet biological warfare program. Crit Rev Microbiol 2006 32 : 47 64.
18. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 1999 96 : 14043 14048.
19. Flexner S. The pathology of bubonic plague. Am J Med Sci 1901 122 : 396 416.
20. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci USA 2006 103 : 5526 5530.
21. Lien-Teh W. A Treatise on Pneumonic Plague. Geneva : Leaugue of Nations Health Organisation, 1926.
22. Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 2005 40 : 1166 1172.
23. Inglesby TV, et al. Plague as a biological weapon: medical and public health management. Working group on civilian biodefense. JAMA 2000 283 : 2281 2290.
24. Cornelis GR. Yersinia type III secretion: send in the effectors. J Cell Biol 2002 158 : 401 408.
25. Brubaker RR. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003 71 : 3673 3681.
26. Viboud GI, Bliska JB. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 2005 59 : 69 89.
27. Heesemann J, Sing A, Trulzsch K. Yersinia's stratagem: targeting innate and adaptive immune defense. Curr Opin Microbiol 2006 9 : 55 61.
28. Finegold MJ. Pneumonic plague in monkeys. An electron microscopic study. Am J Pathol 1969 54 : 167 185.
29. Lathem WW, Crosby SD, Miller VL, Goldman WE. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci USA 2005 102 : 17786 17791.
30. Lathem WW, Price PA, Miller VL, Goldman WE. A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 2007 315 : 509 513.
31. Bubeck SS, Cantwell AM, Dube PH. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun 2007 75 : 697 705.
32. Motin VL, et al. Temporal global changes in gene expression during temperature transition in Yersinia pestis. J Bacteriol 2004 186 : 6298 6305.
33. Cavanaugh DC, Randall R. The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. J Immunol 1959 83 : 348 363.
34. Rowland S. The morphology of plague bacillus. J Hyg 1914 13 (Suppl.) : 418 422.
35. Schutze H. Studies in B. Pestis antigens: I. The antigens and immunity reactions of B. pestis. Br J Exp Pathol 1932 13 : 284 288.
36. Chen TH, Elberg SS. Scanning electron microscopic study of virulent Yersinia pestis and Yersinia pseudotuberculosis type 1. Infect Immun 1977 15 : 972 977.
37. Du Y, Rosqvist R, Forsberg A. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun 2002 70 : 1453 1460.
38. Winter CC, Cherry WB, Moody MD. An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. Bull World Health Organ 1960 23 : 408 409.
39. Friedlander AM, et al. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis 1995 21 (Suppl.) : S178 S181.
40. Welkos SL, Davis KM, Pitt LM, Worsham PL, Freidlander AM. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib Microbiol Immunol 1995 13 : 299 305.
41. Drozdov IG, et al. Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis. J Med Microbiol 1995 42 : 264 268.
42. Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Friedlander AM. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med 1996 120 : 156 163.
43. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. Plague bacteria target immune cells during infection. Science 2005 309 : 1739 1741.
44. Burrows TW, Bacon GA. The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br J Exp Pathol 1956 37 : 481 493.
45. Janssen WA, Lawton WD, Fukui GM, Surgalla MJ. The pathogenesis of plague. I. A study of the correlation between virulence and relative phagocytosis resistance of some strains of Pasteurella pestis. J Infect Dis 1963 113 : 139 143.
46. Lawton WD, Erdman RL, Surgalla MJ. Biosynthesis and purification of V and W antigen in Pateurella pestis. J Immunol 1963 91 : 179 184.
47. Une T, Brubaker RR. Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 1984 133 : 2226 2230.
48. r phenotypes of yersiniae. Infect Immun 1984 43 : 895 900.
49. Welkos S, Friedlander A, McDowell D, Weeks J, Tobery S. V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb Pathog 1998 24 : 185 196.
50. Pujol C, Bliska JB. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin Immunol 2005 114 : 216 226.
51. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ. Kinetics of disease progression and host response in a rat model of bubonic plague. Am J Pathol 2005 166 : 1427 1439.
52. Janssen WA, Surgalla MJ. Plague bacillus: survival within host phagocytes. Science 1969 163 : 950 952.
53. Straley SC, Harmon PA. Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants. Infect Immun 1984 45 : 649 654.
54. Lukaszewski RA, Kenny DJ, Taylor R, Rees DG, Hartley MG, Oyston PC. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils. Infect Immun 2005 73 : 7142 7150.
55. Zauberman A, et al. Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun 2006 74 : 3239 3250.
56. Pujol C, Grabenstein JP, Perry RD, Bliska JB. Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus. Proc Natl Acad Sci USA 2005 102 : 12909 12914.
57. Oyston PC, et al. The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun 2000 68 : 3419 3425.
58. Grabenstein JP, Fukuto HS, Palmer LE, Bliska JB. Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of Yersinia pestis in macrophages. Infect Immun 2006 74 : 3727 3741.
59. Sha J, et al. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Infect Immun 2008 76 : 1390 1409.
60. Sing A, Reithmeier-Rost D, Granfors K, Hill J, Roggenkamp A, Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci USA 2005 102 : 16049 16054.
61. Reithmeier-Rost D, et al. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis. Microbes Infect 2007 9 : 997 1002.
62. Pouliot K, Pan N, Wang S, Lu S, Lien E, Goguen JD. Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis. Infect Immun 2007 75 : 3571 3580.
63. Philipovskiy AV, et al. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis. Infect Immun 2005 73 : 1532 1542.
64. Kawahara K, Tsukano H, Watanabe H, Lindner B, Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect Immun 2002 70 : 4092 4098.
65. Rebeil R, Ernst RK, Gowen BB, Miller SI, Hinnebusch BJ. Variation in lipid A structure in the pathogenic yersiniae. Mol Microbiol 2004 52 : 1363 1373.
66. Montminy SW, et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 2006 7 : 1066 1073.
67. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 2004 72 : 4589 4602.
68. Sebbane F, et al. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc Natl Acad Sci USA 2006 103 : 11766 11771.
69. Cowan C, Jones HA, Kaya YH, Perry RD, Straley SC. Invasion of epithelial cells by Yersinia pestis: evidence for a Y. pestis-specific invasin. Infect Immun 2000 68 : 4523 4530.
70. Viboud GI, So SS, Ryndak MB, Bliska JB. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis. Mol Microbiol 2003 47 : 1305 1315.
71. Zhou L, Tan A, Hershenson MB. Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells. Respir Physiol Neurobiol 2004 140 : 89 97.
72. Lahteenmaki K, Edelman S, Korhonen TK. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol 2005 13 : 79 85.
73. Brubaker RR, Beesley ED, Surgalla MJ. Pasteurella pestis: role of pesticin I and iron in experimental plague. Science 1965 149 : 422 424.
74. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science 1992 258 : 1004 1007.
75. Meyer KF. Effectiveness of live or killed plague vaccines in man. Bull World Health Organ 1970 42 : 653 666.
76. Meyer KF, Cavanaugh DC, Bartelloni PJ, Marshall JD Jr. Plague immunization. I. Past and present trends. J Infect Dis 1974 129 (Suppl.) : S13 S18.
77. Titball RW, Williamson ED. Yersinia pestis (plague) vaccines. Expert Opin Biol Ther 2004 4 : 965 973.
78. Haffkine WM. Remarks on the plague prophylactic fluid. Br Med J 1897 1 : 1461.
79. Taylor J. Haffkine's plague vaccine. Ind Med Res Memoirs 1933 27 : 1 125.
80. Cavanaugh DC, et al. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J Infect Dis 1974 129 (Suppl.) : S37 S40.
81. Cohen RJ, Stockard JL. Pneumonic plague in an untreated plague-vaccinated individual. JAMA 1967 202 : 365 366.
82. Baker EE, Sommer H, Foster LE, Meyer E, Meyer KF. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J Immunol 1952 68 : 131 145.
83. Ehrenkranz NJ, Meyer KF. Studies on immunization against plague. VIII. Study of three immunizing preparations in protecting primates against pneumonic plague. J Infect Dis 1955 96 : 138 144.
84. Andrews GP, Heath DG, Anderson GW Jr., Welkos SL, Friedlander AM. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 1996 64 : 2180 2187.
85. Anderson GW Jr., et al. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am J Trop Med Hyg 1997 56 : 471 473.
86. Hill J, Copse C, Leary S, Stagg AJ, Williamson ED, Titball RW. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infect Immun 2003 71 : 2234 2238.
87. Worsham PL, Stein MP, Welkos SL. Construction of defined F1 negative mutants of virulent Yersinia pestis. Contrib Microbiol Immunol 1995 13 : 325 328.
88. Sato K, Nakajima R, Hara F, Une T, Osada Y. Preparation of monoclonal antibody to V antigen from Yersinia pestis. Contrib Microbiol Immunol 1991 12 : 225 229.
89. Nakajima R, Brubaker RR. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 1993 61 : 23 31.
90. Motin VL, Nakajima R, Smirnov GB, Brubaker RR. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 1994 62 : 4192 4201.
91. Anderson GW Jr., et al. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun 1996 64 : 4580 4585.
92. Anderson GW Jr., Heath DG, Bolt CR, Welkos SL, Friedlander AM. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am J Trop Med Hyg 1998 58 : 793 799.
93. Roggenkamp A, Geiger AM, Leitritz L, Kessler A, Heesemann J. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 1997 65 : 446 451.
94. Williamson ED, et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 1995 12 : 223 230.
95. Williamson ED, et al. Local and systemic immune response to a microencapsulated sub-unit vaccine for plague. Vaccine 1996 14 : 1613 1619.
96. Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 1997 15 : 1079 1084.
97. Jones SM, Day F, Stagg AJ, Williamson ED. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 2000 19 : 358 366.
98. Heath DG, et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 1998 16 : 1131 1137.
99. Williamson ED, et al. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 2005 73 : 3598 3608.
100. Morris SR. Development of a recombinant vaccine against aerosolized plague. Vaccine 2007 25 : 3115 3117.
101. Abdy M. The "Animal Rule". In : 5th Annual Biodefense Vaccines & Therapeutics Policy, Funding, and Development Conference 2007. Washington, DC, 2007.
102. Pitt ML. Non-human primates as a model for pneumonic plague. In : Animals Models and Correlates of Protection for Plague Vaccines Workshop; 2004 Oct. 13-14, 2004. Gaithersburg, MD, 2004.
103. Goodin JL, et al. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. Protein Expr Purif 2007 53 : 63 79.
104. DeBord KL, et al. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun 2006 74 : 4910 4914.
105. Jones T, et al. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine 2006 24 : 1625 1632.
106. Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infect Immun 2005 73 : 5256 5261.
107. Eyles JE, Williamson ED, Spiers ID, Stagg AJ, Jones SM, Alpar HO. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. J Control Release 2000 63 : 191 200.
108. Honko AN, Sriranganathan N, Lees CJ, Mizel SB. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 2006 74 : 1113 1120.
109. Wang S, et al. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine 2004 22 : 3348 3357.
110. Oyston PC, Williamson ED, Leary SE, Eley SM, Griffin KF, Titball RW. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect Immun 1995 63 : 563 568.
111. Titball RW, Howells AM, Oyston PC, Williamson ED. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infect Immun 1997 65 : 1926 1930.
112. Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb Pathog 1997 23 : 167 179.
113. Garmory HS, Griffin KF, Brown KA, Titball RW. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine 2003 21 : 3051 3057.
114. Yang X, et al. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 2007 178 : 1059 1067.
115. Palin A, et al. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine 2007 25 : 741 750.
116. Chiuchiolo MJ, Boyer JL, Krause A, Senina S, Hackett NR, Crystal RG. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. J Infect Dis 2006 194 : 1249 1257.
117. Andrews GP, et al. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect Immun 1999 67 : 1533 1537.
118. Matson JS, Durick KA, Bradley DS, Nilles ML. Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol 2005 5 : 38.
119. Swietnicki W, Powell BS, Goodin J. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague. Protein Expr Purif 2005 42 : 166 172.
120. Murphy BS, Wulff CR, Garvy BA, Straley SC. Yersinia pestis YadC: a novel vaccine candidate against plague. Adv Exp Med Biol 2007 603 : 400 414.
121. Tanabe M, et al. The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection. Infect Immun 2006 74 : 3687 3691.
122. Kolle W, Otto R. Weitere Untersuchungen uber die Pestimmunitat. Zeitschr F Hyg 1904 48 : 399 428.
123. Strong RP. Vaccination against plague. Phillipine J Sci 1906 1 : 181 190.
124. Strong RP. Protective inoculation against plague. J Med Res 1908 18 : 325 346.
125. Girard G. Immunity in plague. Results of 30 years of work on the "Pasteurella pestis Ev" (Girard and Robic) strain. Biol Med (Paris) 1963 52 : 631 731.
126. Meyer KF, Smith G, Foster L, Brookman M, Sung M. Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J Infect Dis 1974 129 (Suppl.) : S85 S112.
127. Russell P, Eley SM, Hibbs SE, Manchee RJ, Stagg AJ, Titball RW. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 1995 13 : 1551 1556.
128. Welkos S, Pitt ML, Martinez M, Friedlander A, Vogel P, Tammariello R. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 2002 20 : 2206 2214.
129. Aleksandrov NI, et al. Study of a method of aerosol immunization with powdered plague vaccine in extensive population groups. Zh Mikrobiol Epidemiol Immunobiol 1963 40 : 22 28.
130. Feodorova VA, et al. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine 2007 25 : 7620 7628.
131. Flashner Y, et al. Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect Immun 2004 72 : 908 915.
132. Bubeck SS, Dube PH. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine. Clin Vaccine Immunol 2007 14 : 1235 1238.
133. Green M, et al. The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol Med Microbiol 1999 23 : 107 113.
134. Williamson ED, et al. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. Microb Pathog 2007 42 : 11 21.
135. Bashaw J, Norris S, Weeks S, Trevino S, Adamovicz JJ, Welkos S. Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol 2007 14 : 605 616.
136. Meyer KF. Immunity in plague: a critical consideration of some recent studies. J Immunol 1950 64 : 139 163.
137. Jawetz E, Meyer KF. Studies on plague immunity in experimental animals. I. Protective and antitoxic antibodies in the serum of actively immunized animals. J Immunol 1944 49 : 1 14.
138. Jawetz E, Meyer KF. Studies on plague immunity in experimental animals. II. Some factors of the immunity mechanism in bubonic plague. J Immunol 1944 49 : 15 30.
139. Cowan C, Philipovskiy AV, Wulff-Strobel CR, Ye Z, Straley SC. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect Immun 2005 73 : 6127 6137.
140. Parent MA, Wilhelm LB, Kummer LW, Szaba FM, Mullarky IK, Smiley ST. Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection. Infect Immun 2006 74 : 3381 3386.
141. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997 15 : 323 350.
142. Elvin SJ, Williamson ED. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. Microb Pathog 2004 37 : 177 184.
143. Bartra SS, et al. Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infect Immun 2008 76 : 612 622.
144. Pettersson J, et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 1999 32 : 961 976.
145. Fields KA, Nilles ML, Cowan C, Straley SC. Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect Immun 1999 67 : 5395 5408.
146. Weeks S, Hill J, Friedlander A, Welkos S. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb Pathog 2002 32 : 227 237.
147. Zauberman A, et al. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Vaccine 2008 26 : 1616 1625.
148. Wong JF, Elberg SS. Cellular immune response to Yersinia pestis modulated by product(s) from thymus-derived lymphocytes. J Infect Dis 1977 135 : 67 78.
149. Finegold MJ, Petery JJ, Berendt RF, Adams HR. Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis. Am J Pathol 1968 53 : 99 114.
150. Nakajima R, Motin VL, Brubaker RR. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 1995 63 : 3021 3029.
151. Straley SC, Cibull ML. Differential clearance and host-pathogen interactions of YopE- and YopK- YopL- Yersinia pestis in BALB/c mice. Infect Immun 1989 57 : 1200 1210.
152. Degen JL, Bugge TH, Goguen JD. Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 2007 5 (Suppl.) : 24 31.
153. Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993 11 : 129 163.
154. Velan B, Bar-Haim E, Zauberman A, Mamroud E, Shafferman A, Cohen S. Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration. Infect Immun 2006 74 : 6365 6376.
155. Trulzsch K, et al. Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model. J Immunol 2005 174 : 4244 4251.
156. Autenrieth IB, Tingle A, Reske-Kunz A, Heesemann J. T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect Immun 1992 60 : 1140 1149.
157. Heesemann J, Gaede K, Autenrieth IB. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS 1993 101 : 417 429.
158. Noll A, Roggenkamp A, Heesemann J, Autenrieth IB. Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis. Infect Immun 1994 62 : 2784 2791.
159. Alonso JM, Vilmer E, Mazigh D, Mollaret HH. Mechanisms of acquired resistance to plague in MIce infected by Yersinia enterocolitica 03. Curr Microbiol 1980 4 : 117 122.
160. Wake A, Sutoh Y. Mechanims of protection against virulent Yersinia pestis infection without participation of humoral antibody: H-2 restriction in athymic mouse model. Curr Microbiol 1983 8 : 79 84.
161. Parent MA, et al. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 2005 73 : 7304 7310.
162. Philipovskiy AV, Smiley ST. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect Immun 2007 75 : 878 885.
163. Leary SE, Williamson ED, Griffin KF, Russell P, Eley SM, Titball RW. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun 1995 63 : 2854 2858.
164. Williamson ED, Vesey PM, Gillhespy KJ, Eley SM, Green M, Titball RW. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol 1999 116 : 107 114.
165. Parent MA, et al. Yersinia pestis V protein epitopes recognized by CD4 T cells. Infect Immun 2005 73 : 2197 2204.
166. Shim HK, et al. Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis. Immunology 2006 119 : 385 392.
167. Do Y, et al. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells. Eur J Immunol 2008 38 : 20 29.
168. Khan AA, Babu JP, Gupta G, Rao DN. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Vaccine 2008 26 : 316 332.